Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

Details for Australian Patent Application No. 2006244885 (hide)

Owner Medarex, Inc. Ono Pharmaceutical Co., Ltd.

Inventors Cardarelli, Josephine M.; Chen, Bing; Selby, Mark J.; Korman, Alan J.; Wang, Changyu; Srinivasan, Mohan

Agent Spruson & Ferguson

Pub. Number AU-B-2006244885

PCT Pub. Number WO2006/121168

Priority 60/738,434 21.11.05 US; 60/679,466 09.05.05 US; 60/748,919 08.12.05 US

Filing date 2 May 2006

Wipo publication date 16 November 2006

Acceptance publication date 31 March 2011

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/121168 Priority application(s): WO2006/121168

31 March 2011 Application Accepted

  Published as AU-B-2006244885

28 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006244899-Intermolecular compound of fatty acid triglyceride

2006244873-Medical composition for promotion of skin regeneration